Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-084815
Filing Date
2016-02-29
Accepted
2016-02-29 11:02:42
Documents
2
Period of Report
2016-02-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v432959_3.html 3  
1 OWNERSHIP DOCUMENT v432959_3.xml 3 7358
2 EXHIBIT 24 v432959_ex24.htm EX-24 8718
  Complete submission text file 0001144204-16-084815.txt   17579
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
SAENGER BRADLEY (Reporting) CIK: 0001668150 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36019 | Film No.: 161465520